Don't get me wrong, I think most of your notions are wrong, but everyone should of know it was going to be used in clinical research first. That was expressed by GC a year ago and than submitted to the FDA on the gathering of data. Now with MANF, Elt, and a 20 million credit line from LPC the stock has room to run. How high, no one knows. All speculation. Specially a partnership for either of those 2 drugs and grants this could run to $$$ depending on how big.
News 
Market Data 
Discover 
AI
